Evolus Inc - ESG Rating & Company Profile powered by AI
Industry Group:Pharmaceuticals
The ESG score covers 17 UN SDGs including: 'Good Health & Wellbeing', 'Industry, Innovation & Infrastructure' and 'Peace, Justice & Strong Institutions'. Check the end of this page for potential risks for Evolus Inc based on industry, geography and size. Other corporations in the rating peer group for Evolus Inc are displayed.
Evolus Inc in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 2.3; made up of an environmental score of 2.0, social score of 0.0 and governance score of 4.8.
SDG Transparency Score for Evolus Inc ⓘ
2.3
Low Impact0 - 3
Medium
4 - 6
High
7 - 10
What drives the score for Evolus Inc ⓘ
2.0
Environmental
0.0
Social
4.8
Governance
Peer Group Comparison
| Rank | Company | SDG Transparency Score ⓘ | Performance |
|---|---|---|---|
| 1 | Caladrius Biosciences Inc | 8.0 | High |
| 1 | Can Fite Biopharma Ltd | 8.0 | High |
| ... | ... | ... | |
| 1512 | Sol Gel Technologies Ltd | 2.4 | Medium |
| 1512 | Windtree Therapeutics Inc | 2.4 | Medium |
| 1529 | Evolus Inc | 2.3 | Medium |
| 1529 | ANI Pharmaceuticals Inc | 2.3 | Medium |
| 1529 | Aarti Drugs Ltd | 2.3 | Medium |
| ... | ... | ... | |
| 1970 | Zyden Gentec Ltd | 0.0 | Low |
| 1970 | iNtRON Biotechnology Inc | 0.0 | Low |
| ... | ... | ... |
Frequently Asked Questions
Does Evolus Inc have an accelerator or VC vehicle to help deliver innovation?
Does Evolus Inc disclose current and historical energy intensity?
Does Evolus Inc report the average age of the workforce?
Does Evolus Inc reference operational or capital allocation in relation to climate change?
Does Evolus Inc disclose its ethnicity pay gap?
Does Evolus Inc disclose cybersecurity risks?
Does Evolus Inc use carbon offsets or credits exclusively for residual emissions (typically less than ~0.5–5% of total emissions)?
Does Evolus Inc offer flexible work?
Does Evolus Inc have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Does Evolus Inc disclose the number of employees in R&D functions?
Does Evolus Inc plan to change its portfolio composition to lower the emissions intensity of its energy mix (e.g., by shifting from oil to gas, or by adding lower-carbon options like hydrogen, e-fuels, bioenergy, etc.)?
Does Evolus Inc conduct supply chain audits?
Does Evolus Inc disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Is there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Does Evolus Inc conduct 360 degree staff reviews?
Does Evolus Inc disclose the individual responsible for D&I?
Does Evolus Inc disclose current and historical air emissions?
Is there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Is executive remuneration linked to climate performance?
Does the Board describe its role in the oversight of climate-related risks and opportunities?
Does Evolus Inc disclose current and / or historical scope 2 emissions?
Does Evolus Inc disclose water use targets?
Does Evolus Inc have careers partnerships with academic institutions?
Did Evolus Inc have a product recall in the last two years?
Does Evolus Inc disclose incidents of discrimination?
Does Evolus Inc allow for Work Councils/Collective Agreements to be formed?
Has Evolus Inc issued a profit warning in the past 24 months?
Does Evolus Inc disclose parental leave metrics?
Does Evolus Inc disclose climate scenario or pathway analysis?
Does Evolus Inc disclose current and / or historical scope 1 emissions?
Does Evolus Inc explicitly state that carbon offsets or credits are separate from its emissions-reduction progress or that they are not counted toward its emissions-reduction targets?
Are Operating Expesnses linked to emissions reduction?
Does Evolus Inc disclose the pay ratio of women to men?
Does Evolus Inc support suppliers with sustainability related research and development?
Does Evolus Inc disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Does Evolus Inc reflect climate-related risks in its financial statements?
Is there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Is Evolus Inc involved in embryonic stem cell research?
Does Evolus Inc disclose GHG and Air Emissions intensity?
Does Evolus Inc disclose its waste policy?
Does Evolus Inc report according to TCFD requirements?
Does Evolus Inc plan to mitigate emissions from future new production assets through measures such as electrifying equipment, carbon capture and storage, repurposing waste gas, methane leak detection and repair, eliminating flaring, etc.?
Does Evolus Inc disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Does Evolus Inc disclose energy use targets?
Does Evolus Inc disclose its Renewable Energy targets?
Are emissions metrics verified by STBi?
Does Evolus Inc have a policy relating to cyber security?
Potential Risks for Evolus Inc
These potential risks are based on the size, segment and geographies of the company.
Evolus, Inc., a performance beauty company, provides medical aesthetic products for physicians and their patients in the United States. It offers Jeuveau, a proprietary 900 kilodalton purified botulinum toxin type A formulation for the temporary improvement in the appearance of moderate to severe glabellar lines in adults. The company was incorporated in 2012 and is headquartered in Newport Beach, California.